Latest filing published 08 Jun 2016 for Cipher Pharmaceuticals Inc..
No signal scores available.
Norman Charles Evans appears in our data through filings on Cipher Pharmaceuticals Inc. shares, published by SEDI. The record holds 2 filings, for trades running from 15 March 2016 to 3 June 2016.
Sales make up the whole of the open-market record (1 sale). The totals do not cover 1 filing with an undisclosed amount. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 8 June 2016: an open-market sale, in Cipher Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations